methylprednisolone has been researched along with Peritoneal Carcinomatosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doki, Y; Hagi, T; Kurokawa, Y; Makino, T; Miyazaki, Y; Mori, M; Nakajima, K; Takahashi, T; Tanaka, K; Taniguchi, Y; Yamasaki, M | 1 |
| Bisot-Locard, S; Bourdeix, I; Brixi, H; François, E; Laval, G; Mayer, F; Nguyen, T; Rousselot, H; Terrebonne, E; Toussaint-Martel, S; Zelek, L | 1 |
| Bamias, A; Bozas, G; Dimopoulos, MA; Efstathiou, E; Galani, E; Kastritis, E; Papadimitriou, C; Zorzou, MP | 1 |
1 trial(s) available for methylprednisolone and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction.
Topics: Aged; Antiemetics; Carcinoma; Device Removal; Double-Blind Method; Drug Therapy, Combination; Female; France; Gastrointestinal Agents; Humans; Intestinal Obstruction; Intubation, Gastrointestinal; Karnofsky Performance Status; Male; Methylprednisolone; Middle Aged; Octreotide; Peritoneal Neoplasms; Pilot Projects; Vomiting | 2012 |
2 other study(ies) available for methylprednisolone and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Methylprednisolone Inhibits Tumor Growth and Peritoneal Seeding Induced by Surgical Stress and Postoperative Complications.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Interleukin-6; Male; Methylprednisolone; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local; Neoplasm Seeding; Peritoneal Neoplasms; Postoperative Complications; Prognosis; Randomized Controlled Trials as Topic; Signal Transduction; Stomach Neoplasms; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Carboplatin hypersensitivity reactions: a single institution experience.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Carboplatin; Dexamethasone; Drug Hypersensitivity; Endometrial Neoplasms; Female; Histamine H1 Antagonists; Humans; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Salvage Therapy; Urinary Bladder Neoplasms | 2005 |